2024
Potential use of epigenetic clocks to understand factors associated with aging at the population level and in public health
Martínez-Magaña J, Hurtado-Soriano J, Montalvo-Ortiz J, Gomez-Verjan J. Potential use of epigenetic clocks to understand factors associated with aging at the population level and in public health. Gaceta Médica De México 2024, 160: 357-359. PMID: 39602607, DOI: 10.24875/gmm.m24000897.Peer-Reviewed Original ResearchTowards a Novel Frontier in the Use of Epigenetic Clocks in Epidemiology
Martínez-Magaña J, Hurtado-Soriano J, Rivero-Segura N, Montalvo-Ortiz J, Garcia-delaTorre P, Becerril-Rojas K, Gomez-Verjan J. Towards a Novel Frontier in the Use of Epigenetic Clocks in Epidemiology. Archives Of Medical Research 2024, 55: 103033. PMID: 38955096, DOI: 10.1016/j.arcmed.2024.103033.Peer-Reviewed Original ResearchImpact of public health interventionsHealth problems associated with agingPublic health interventionsPublic health strategiesEpigenetic clocksEfficacy of interventionsProblems associated with agingBiological agePublic health concernHealth interventionsHealth strategiesAssociated with ageDNA methylation levelsHuman phenomeHealthy agingHealth concernEpigenetic ageMultiple traitsHealthMethylation levelsInterventionAssociationAgeEpidemiological contextHealth span
2023
Aftereffects in Epigenetic Age Related to Cognitive Decline and Inflammatory Markers in Healthcare Personnel with Post-COVID-19: A Cross-Sectional Study
Nolasco-Rosales G, Alonso-García C, Hernández-Martínez D, Villar-Soto M, Martínez-Magaña J, Genis-Mendoza A, González-Castro T, Tovilla-Zarate C, Guzmán-Priego C, Martínez-López M, Nicolini H, Juárez-Rojop I. Aftereffects in Epigenetic Age Related to Cognitive Decline and Inflammatory Markers in Healthcare Personnel with Post-COVID-19: A Cross-Sectional Study. International Journal Of General Medicine 2023, 16: 4953-4964. PMID: 37928957, PMCID: PMC10625328, DOI: 10.2147/ijgm.s426249.Peer-Reviewed Original ResearchInflammatory markersPost-COVID conditionsHealthcare personnelLow PLRCognitive impairmentMini-Mental State Examination testEpigenetic ageCross-sectional studyIndicators of severityMontreal Cognitive AssessmentMild cognitive impairmentHigh NLRNeuropsychiatric manifestationsNeurological symptomsPsychiatric manifestationsHealthcare workersHigh MLRNeurocognitive changesPossible associationCognitive declinePhysical healthPLRCognitive AssessmentExamination testsAge